King Pharmaceuticals, Inc. and Alpharma, Inc. have announced a merger agreement under which King will acquire all of the outstanding shares of Class A common stock of Alpharma for $37 per share in ...

Generic pharmaceutical company Alpharma (NYSE: ALO) in Fort Lee entered into a development agreement with Orchid Chemicals & Pharmaceuticals of Chennai, India. Orchid will develop, manufacture and ...

King Pharmaceuticals has increased its bid to acquire Alpharma but has chosen to take the hostile route after its initial offer was firmly rejected by the board. King Pharmaceuticals has increased its ...

King Pharmaceuticals has finally prevailed over Alpharma now that the specialty pharmaceutical company has agreed to be taken over by its royal competitor. Bristol, Tenn.-based King Pharmaceuticals ...

Alpharma lowers its financial guidance for 2008. On Monday, up-and-coming specialty pharma Alpharma (NYSE: ALO) revised its 2008 financial guidance, and investors wrongly heckled its newly lowered ...

Alpharma (NYSE, ALO), a Fort Lee-based pharmaceutical company that makes specialty generic and proprietary human pharmaceuticals and animal health products, was in the news last week. The company said ...

NEW YORKNEW YORK — Alpharma Inc. has finally agreed to King Pharmaceuticals Inc.’s $1.6 billion cash takeover offer, ending the drugmakers’ months-long battle. On Monday, Bristol, Tenn.-based King ...

Despite a rejection from Alpharma's board, King Pharmaceuticals has decided to go public with its offer for the specialty pharmaceutical company anyway. Despite the response from the board and the ...

King Pharmaceuticals, which has been courting Alpharma for months now, has finally gotten its wish. Alpharma rejected King's first offer of $1.4 billion back in September--although it was a 49 percent ...

CUPERTINO, Calif., Sept. 22 DURECT Corporation(Nasdaq: DRRX) announced today that it has entered into a development andlicense agreement with an affiliate of Alpharma Inc. (NYSE: ALO) granting ...

If imitation is the sincerest form of flattery, then Endo Pharmaceuticals (Nasdaq: ENDP) should feel complimented by Alpharma (NYSE: ALO). On Wednesday, Alpharma announced that it was selling its ...

Getting your Trinity Audio player ready... DENVER—Colorado Attorney General John Suthers says Colorado will receive $79,208 as part of a settlement with Alpharma Inc. over accusations of fraud.